EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology

Marina Skorkina, Tatiana Kovaleva, Irina Predeina iD, Nikita Smirnov iD, Irina Mukhina iD

Cells · 2026

DOI: 10.3390/cells15040324 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Marina Skorkina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine, Privolzhsky Research Medical University, 10/1 Minin Sq., Nizhniy Novgorod 603005, Russia. Hauptthemen laut MEDLINE: PAX6 Transcription Factor, Neurogenesis, Aniridia, Neurodegenerative Diseases. Die Arbeit nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Governmental assignment of the Ministry of Health of Russian Federation, Ministry of Health of Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pax6 is a multifunctional transcription factor that orchestrates cell cycle progression at distinct stages of early embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways associated with pathological processes. Within this framework, Pax6 is regarded as an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The present review aims to examine published studies describing various Pax6-dependent molecular pathways to identify common principles and condition-specific differences in Pax6-regulated cascades in health and disease. These insights may contribute to the conceptual foundation for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data demonstrating a central role of Pax6 in governing the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PAX6 Transcription FactorNeurogenesisAniridiaNeurodegenerative DiseasesNeoplasmsMolecular Targeted TherapyHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

Pax6aniridiacell cycleneurodegenerationneurogenesisoncologyproliferation

Substanzen

PAX6 Transcription FactorPAX6 protein, human

Autor:innen und Institutionen

  • Institute of Fundamental Medicine, Privolzhsky Research Medical University, 10/1 Minin Sq., Nizhniy Novgorod 603005, Russia.

ORCID-Profile: Irina Predeina, Nikita Smirnov, Irina Mukhina

Förderung

  • Governmental assignment of the Ministry of Health of Russian Federation
  • Ministry of Health of Russian Federation

Zitieren

APA

Skorkina, M., Kovaleva, T., Predeina, I., Smirnov, N., & Mukhina, I. (2026). Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology. Cells. https://doi.org/10.3390/cells15040324

Vancouver

Skorkina M, Kovaleva T, Predeina I, Smirnov N, Mukhina I. Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology. Cells. 2026. doi:10.3390/cells15040324

BibTeX
@article{Skorkina2026,
  author = {Skorkina, Marina and Kovaleva, Tatiana and Predeina, Irina and Smirnov, Nikita and Mukhina, Irina},
  title = {Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15040324}
}
Kostenlos starten →